• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者左心室肥厚的流行病学

The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus.

作者信息

Dawson A, Morris A D, Struthers A D

机构信息

Division of Medicine and Therapeutics, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.

出版信息

Diabetologia. 2005 Oct;48(10):1971-9. doi: 10.1007/s00125-005-1896-y. Epub 2005 Aug 11.

DOI:10.1007/s00125-005-1896-y
PMID:16094529
Abstract

AIMS/HYPOTHESIS: Patients with type 2 diabetes mellitus are at greater cardiovascular risk than the general population. Although it is widely acknowledged that diabetes is a risk factor for coronary artery disease, the increased prevalence of potentially lethal left ventricular abnormalities in this population is less well appreciated.

METHODS

We carried out an echocardiographic study of 500 subjects with type 2 diabetes mellitus to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular systolic dysfunction (LVSD). We also assessed whether abnormalities in diastolic filling parameters were present.

RESULTS

Of the 371 patients in whom left ventricular mass could be successfully assessed, 264 had LVH (71%). Left ventricular systolic dysfunction was much less common, being present in 16/385 patients (4.2%). Long axis contraction was abnormal in 29/429 patients (6.8%). Diastolic filling abnormalities were present in 178/435 (41%) of patients who could be classified using the selected criteria.

CONCLUSIONS

We conclude that left ventricular abnormalities are common in type 2 diabetic patients. As medical therapy is available for both LVH and LVSD and has been demonstrated to reduce cardiovascular death, these left ventricular abnormalities could be ideal targets for screening, followed by selective therapeutic intervention.

摘要

目的/假设:2型糖尿病患者的心血管风险高于普通人群。尽管糖尿病是冠状动脉疾病的危险因素已被广泛认可,但该人群中潜在致命的左心室异常患病率升高却较少受到重视。

方法

我们对500例2型糖尿病患者进行了超声心动图研究,以评估左心室肥厚(LVH)和左心室收缩功能障碍(LVSD)的患病率。我们还评估了舒张期充盈参数是否存在异常。

结果

在371例能够成功评估左心室质量的患者中,264例有LVH(71%)。左心室收缩功能障碍则少见得多,385例患者中有16例(4.2%)存在该情况。429例患者中有29例(6.8%)长轴收缩异常。在435例可根据选定标准分类的患者中,178例(41%)存在舒张期充盈异常。

结论

我们得出结论,左心室异常在2型糖尿病患者中很常见。由于针对LVH和LVSD均有药物治疗,且已证明可降低心血管死亡风险,这些左心室异常可能是筛查的理想目标,随后进行选择性治疗干预。

相似文献

1
The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus.2型糖尿病患者左心室肥厚的流行病学
Diabetologia. 2005 Oct;48(10):1971-9. doi: 10.1007/s00125-005-1896-y. Epub 2005 Aug 11.
2
Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study.糖尿病对高血压合并左心室肥厚患者治疗引起的左心室结构和功能变化的影响。LIFE研究。
Nutr Metab Cardiovasc Dis. 2009 Jun;19(5):306-12. doi: 10.1016/j.numecd.2008.12.009. Epub 2009 Mar 19.
3
Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.利用利钠肽对人群进行左心室肥厚和左心室收缩功能障碍筛查:达拉斯心脏研究结果
Am Heart J. 2009 Apr;157(4):746-53.e2. doi: 10.1016/j.ahj.2008.12.017. Epub 2009 Feb 20.
4
Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics.2型糖尿病患者的超声心动图异常及其与症状和临床特征的关系。
Diab Vasc Dis Res. 2016 Sep;13(5):321-30. doi: 10.1177/1479164116645583. Epub 2016 May 21.
5
Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.2型糖尿病患者心电图左心室肥厚患病率的性别差异:卡萨莱蒙费拉托研究
Diabet Med. 2004 Aug;21(8):823-8. doi: 10.1111/j.1464-5491.2004.01246.x.
6
Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension.通过组织多普勒成像对无系统性高血压的糖尿病患者与伴有系统性高血压的糖尿病患者的左心室功能进行比较。
Am J Cardiol. 2004 Aug 1;94(3):395-9. doi: 10.1016/j.amjcard.2004.04.048.
7
Prevalence, predictors and evolution of echocardiographically defined cardiac abnormalities in adults with type 1 diabetes: an observational cohort study.1 型糖尿病成人中超声心动图定义的心脏异常的患病率、预测因素和演变:一项观察性队列研究。
J Diabetes Complications. 2014 Jan-Feb;28(1):22-8. doi: 10.1016/j.jdiacomp.2013.09.013. Epub 2013 Oct 7.
8
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls.通过全面超声心动图评估识别2型糖尿病患者中的明确糖尿病性心肌病:与非糖尿病体重匹配对照的横断面比较。
J Diabetes. 2015 Nov;7(6):779-90. doi: 10.1111/1753-0407.12239. Epub 2015 Jan 15.
9
Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago Hospital.穆拉戈医院新诊断糖尿病患者超声心动图异常的患病率、类型及相关因素。
Afr Health Sci. 2016 Mar;16(1):183-93. doi: 10.4314/ahs.v16i1.25.
10
Changes in left ventricular structure and function following renal artery revascularization.肾动脉血运重建术后左心室结构和功能的变化。
Ann Vasc Surg. 2010 Jan;24(1):80-4. doi: 10.1016/j.avsg.2009.05.004. Epub 2009 Jul 23.

引用本文的文献

1
Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus.非酒精性脂肪性肝病纤维化评分与维生素D缺乏对2型糖尿病患者左心室肥厚及舒张功能受损的相互作用。
Diabetol Metab Syndr. 2025 Aug 1;17(1):307. doi: 10.1186/s13098-025-01808-3.
2
Association between metabolic visceral fat score and left ventricular hypertrophy in individuals with type 2 diabetes.2型糖尿病患者代谢性内脏脂肪评分与左心室肥厚之间的关联
Diabetol Metab Syndr. 2025 Mar 6;17(1):81. doi: 10.1186/s13098-025-01648-1.
3

本文引用的文献

1
Hypothetical economic analysis of screening for left ventricular hypertrophy in high-risk normotensive populations.高危正常血压人群左心室肥厚筛查的假设性经济分析。
QJM. 2004 Feb;97(2):87-93. doi: 10.1093/qjmed/hch016.
2
Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both.高血压、糖尿病或两者皆有的患者中主动脉僵硬度与左心室舒张功能的关系。
Heart. 2004 Jan;90(1):37-43. doi: 10.1136/heart.90.1.37.
3
Left ventricular mass and geometry and the risk of ischemic stroke.左心室质量、几何形状与缺血性中风风险
Sex differences of visceral fat with cardiac structure and function in type 2 diabetes: A cross-sectional study.
2 型糖尿病患者内脏脂肪的性别差异与心脏结构和功能的关系:一项横断面研究。
J Diabetes. 2024 Nov;16(11):e70023. doi: 10.1111/1753-0407.70023.
4
Ethnicity differences in geometric remodelling and myocardial composition in hypertension unveiled by cardiovascular magnetic resonance.心血管磁共振揭示高血压患者的几何重塑和心肌成分的种族差异。
Eur Heart J Cardiovasc Imaging. 2024 Jun 28;25(7):901-911. doi: 10.1093/ehjci/jeae097.
5
The cardiovascular changes underlying a low cardiac output with exercise in patients with type 2 diabetes mellitus.2型糖尿病患者运动时心输出量降低背后的心血管变化。
Front Physiol. 2024 Mar 20;15:1294369. doi: 10.3389/fphys.2024.1294369. eCollection 2024.
6
Epidemiology of heart failure in diabetes: a disease in disguise.糖尿病合并心力衰竭的流行病学:一种伪装的疾病。
Diabetologia. 2024 Apr;67(4):574-601. doi: 10.1007/s00125-023-06068-2. Epub 2024 Feb 9.
7
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.法国胰岛素治疗 2 型糖尿病患者实时连续血糖监测与自我血糖监测的成本效用分析。
J Comp Eff Res. 2024 Mar;13(3):e230174. doi: 10.57264/cer-2023-0174. Epub 2024 Jan 31.
8
Nighttime blood pressure and glucose control impacts on left ventricular hypertrophy: The Japan Morning Surge Home Blood Pressure (J-HOP) Study.夜间血压和血糖控制对左心室肥厚的影响:日本晨间血压居家监测(J-HOP)研究。
Hypertens Res. 2024 Feb;47(2):507-514. doi: 10.1038/s41440-023-01487-5. Epub 2023 Oct 30.
9
Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy.钠-葡萄糖协同转运蛋白 2 抑制剂与病理性心肌肥厚。
Curr Drug Targets. 2023;24(13):1009-1022. doi: 10.2174/1389450124666230907115831.
10
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada.加拿大胰岛素治疗 2 型糖尿病患者实时连续血糖监测与自我血糖监测的成本-效用分析
J Comp Eff Res. 2023 Oct;12(10):e230075. doi: 10.57264/cer-2023-0075. Epub 2023 Sep 5.
Stroke. 2003 Oct;34(10):2380-4. doi: 10.1161/01.STR.0000089680.77236.60. Epub 2003 Sep 4.
4
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease.糖尿病和非糖尿病冠心病患者的无症状心肌缺血
Int J Cardiol. 2003 Aug;90(2-3):219-27. doi: 10.1016/s0167-5273(02)00558-2.
5
Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure.血压和胰岛素对体脂与左心室结构之间关系的影响。
Eur Heart J. 2003 Aug;24(16):1500-5. doi: 10.1016/s0195-668x(03)00312-9.
6
Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus.舒张功能障碍与2型糖尿病病情得到良好控制的无症状血压正常患者的心肌代谢改变有关。
J Am Coll Cardiol. 2003 Jul 16;42(2):328-35. doi: 10.1016/s0735-1097(03)00625-9.
7
Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study.
Clin Sci (Lond). 2003 Jul;105(1):59-66. doi: 10.1042/CS20020303.
8
Controlled trial of effect of documented cardiovascular risk scores on prescribing.记录的心血管风险评分对处方影响的对照试验
BMJ. 2003 Feb 1;326(7383):251-2. doi: 10.1136/bmj.326.7383.251.
9
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).高危高血压患者随机接受血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗的主要结局:抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)
JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.
10
Left ventricular mass change during treatment and outcome in patients with essential hypertension.原发性高血压患者治疗期间左心室质量变化及预后
Am J Hypertens. 2002 Dec;15(12):1021-8. doi: 10.1016/s0895-7061(02)03061-3.